GT Diagnostics

GT Diagnostics specializes in developing e-platform tools designed to aid in the diagnosis and monitoring of dementia. The company offers a range of products, from interactive well-being apps for home use to comprehensive diagnostic tools for expert clinicians. Their flagship product, HiPAL Pro, is a self-administered, engaging, and interactive tool that runs on a tablet. It supports clinicians by providing an objective measure of brain connectivity using standard EEG acquisition devices. This tool is particularly useful in primary care facilities and expert centers, where it aids in the evaluation of memory and mental processing speed. GT Diagnostics targets healthcare providers dealing with neurodegenerative diseases, offering solutions that lower the barrier for patients concerned about their mental health to seek further assessment and treatment. The business model focuses on providing these tools to clinicians and healthcare facilities, generating revenue through the sale and licensing of their diagnostic platforms. The company operates in the healthcare and neurodiagnostic markets, addressing the growing demand for effective dementia diagnosis and management solutions.

Keywords: EEG, dementia, neurodiagnostic, clinicians, brain connectivity, cognitive function, healthcare, neurodegenerative, memory assessment, mental processing.